These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7928272)

  • 21. Synthesis and evaluation of gadolinium complexes based on PAMAM as MRI contrast agents.
    Yan GP; Hu B; Liu ML; Li LY
    J Pharm Pharmacol; 2005 Mar; 57(3):351-7. PubMed ID: 15807991
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantification of dechelation of gadopentetate dimeglumine in rats.
    Kasokat T; Urich K
    Arzneimittelforschung; 1992 Jun; 42(6):869-76. PubMed ID: 1418049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elimination of gadolinium-DTPA by peritoneal dialysis.
    Dörsam J; Knopp MV; Schad L; Piesche S; Carl S; Oesingmann N
    Nephrol Dial Transplant; 1995; 10(7):1228-30. PubMed ID: 7478129
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Physical parameters and biological stability of yttrium(III) diethylenetriaminepentaacetic acid derivative conjugates.
    McMurry TJ; Pippin CG; Wu C; Deal KA; Brechbiel MW; Mirzadeh S; Gansow OA
    J Med Chem; 1998 Aug; 41(18):3546-9. PubMed ID: 9719608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of a binary chelate formulation: Could gadolinium based linear contrast agents be rescued by the addition of zinc selective chelates?
    Gibby W; Parish W; Merrill RM; Fernandez D; Anderson CR; Merchel E; Parr R
    Magn Reson Imaging; 2019 May; 58():76-81. PubMed ID: 30639754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonlinear pharmacokinetic modeling of a gadolinium chelate used as a liver-specific contrast agent for magnetic resonance imaging.
    Schuhmann-Giampieri G
    Arzneimittelforschung; 1993 Sep; 43(9):1020-4. PubMed ID: 8240452
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantification of capillary permeability to macromolecular magnetic resonance imaging contrast media in experimental mammary adenocarcinomas.
    Brasch RC; Shames DM; Cohen FM; Kuwatsuru R; Neuder M; Mann JS; Vexler V; Mühler A; Rosenau W
    Invest Radiol; 1994 Jun; 29 Suppl 2():S8-11. PubMed ID: 7928277
    [No Abstract]   [Full Text] [Related]  

  • 28. Energy-dispersive x-ray microscopy to trace gadolinium in tissues.
    Elster AD
    Radiology; 1989 Dec; 173(3):868-70. PubMed ID: 2813798
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics in rats, dogs and monkeys of a gadolinium chelate used as a liver-specific contrast agent for magnetic resonance imaging.
    Schuhmann-Giampieri G; Frenzel T; Schmitt-Willich H
    Arzneimittelforschung; 1993 Aug; 43(8):927-31. PubMed ID: 8216456
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of a phosphodiester linking group on albumin binding, blood half-life, and relaxivity of intravascular diethylenetriaminepentaacetato aquo gadolinium(III) MRI contrast agents.
    McMurry TJ; Parmelee DJ; Sajiki H; Scott DM; Ouellet HS; Walovitch RC; Tyeklár Z; Dumas S; Bernard P; Nadler S; Midelfort K; Greenfield M; Troughton J; Lauffer RB
    J Med Chem; 2002 Aug; 45(16):3465-74. PubMed ID: 12139457
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gadolinium cryptelates as MR contrast agents.
    Knop RH; Frank JA; Dwyer AJ; Girton ME; Naegele M; Schrader M; Cobb J; Gansow O; Maegerstadt M; Brechbiel M
    J Comput Assist Tomogr; 1987; 11(1):35-42. PubMed ID: 3805426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experimental approach to the intra-arterial magnetic resonance imaging contrast media (Gd-DTPA-iodized oil) and new lipophilic gadolinium complex combined with iodized oil.
    Yoshikawa K; Shiono T; Yamashita T; Iwai H; Abe O; Hisamatsu K; Takenaka E
    Invest Radiol; 1994 Jun; 29 Suppl 2():S245-6. PubMed ID: 7928246
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparative pharmacokinetics of gadolinium DTPA and gadolinium chloride.
    Dean PB; Niemi P; Kivisaari L; Kormano M
    Invest Radiol; 1988 Sep; 23 Suppl 1():S258-60. PubMed ID: 3198357
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gadolinium-DTPA transplacental transfer and distribution in fetal tissue in rabbits.
    Novak Z; Thurmond AS; Ross PL; Jones MK; Thornburg KL; Katzberg RW
    Invest Radiol; 1993 Sep; 28(9):828-30. PubMed ID: 8225889
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paramagnetic liposomes as magnetic resonance contrast agents.
    Unger E; Tilcock C; Ahkong QF; Fritz T
    Invest Radiol; 1990 Sep; 25 Suppl 1():S65-6. PubMed ID: 2283260
    [No Abstract]   [Full Text] [Related]  

  • 36. [Artificial contrasting during magnetic resonance tomography].
    Sergeev PV; Panov OV; Egorova SV; Bolotova EN; Shimanovskii NL; Akhadov TA; Sviridov NK
    Vestn Rentgenol Radiol; 1997; (1):45-52. PubMed ID: 9133071
    [No Abstract]   [Full Text] [Related]  

  • 37. Gd-DOTA: characterization of a new paramagnetic complex.
    Bousquet JC; Saini S; Stark DD; Hahn PF; Nigam M; Wittenberg J; Ferrucci JT
    Radiology; 1988 Mar; 166(3):693-8. PubMed ID: 3340763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gadolinium-ethoxybenzyl-DTPA, a new liver-specific magnetic resonance contrast agent. Kinetic and enhancement patterns in normal and cholestatic rats.
    Clément O; Mühler A; Vexler V; Berthezène Y; Brasch RC
    Invest Radiol; 1992 Aug; 27(8):612-9. PubMed ID: 1428739
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elimination of gadolinium-ethoxybenzyl-DTPA in a rat model of severely impaired liver and kidney excretory function. An experimental study in rats.
    Mühler A; Heinzelmann I; Weinmann HJ
    Invest Radiol; 1994 Feb; 29(2):213-6. PubMed ID: 8169100
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renal tolerance of gadolinium-DOTA and gadolinium-DTPA in rats.
    Brillet G; Dubois M; Beaufils H; Bourbouze R; Deray G
    Invest Radiol; 1994 Mar; 29(3):352-4. PubMed ID: 8175311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.